Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant folic acid and methylcobalamin with fluoxetine in depression
TCTR20250818014Phase 3Completed
- Sponsor
- N/A
- Start
- May 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluoxetine, folic acid, mecobalamin in major depressive disorder (MDD), sponsored by N/A. Started May 2025; status: completed.
02
Drugs
fluoxetinefolic acidmecobalamin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20250818014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250818014.